Pricing

Log inSign up

Shinobi Therapeutics

0 followers
‌

Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.

Industries

Biotechnology, Life Sciences

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Dan Kemp
Chief Executive Officer
Collapse
Bhanu Iyer
VP US Operations & HR
Ryosuke Gonotsubo
Chief Of Staff
Molly Cole
Head Of BD And R&d Strategy
Steven Katz
Chief Medical Officer and SVP, Translational Research
Masashi Ochi
VP, Head of Program Leadership and Management
Eiki Maeda
VP, Head of CMC & Manufacturing

Teams

This company has no teams yet

Related companies

Tango Therapeutics

3 followers

Science

8 followers

Cellares

5 followers

Amgen

321 followers

Revvity

12 followers

Gilead Sciences

197 followers

Regeneron

164 followers

Illumina

86 followers

Agilent Technologies

94 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

53 followers